In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Maxillent Ltd.

Latest From Maxillent Ltd.

Maxillent Ltd.

Maxillent Ltd. is developing an alternative to invasive sinus lift procedures for augmenting bone prior to placing dental implants. Its iRaise is a closed sinus-lift implant system that not only augments the bone, but also provides a dental implant, in one simultaneous minimally invasive procedure.

Medical Device

Start-Up Previews, November 2012

This Month's Profile Group: Anti-Infective Start-Ups See Opportunity In An Epidemiological Nightmare features profiles of Arasanis, ContraFect and Fedora Pharmaceuticals. Plus these Start-Ups Across Health Care: Arrowhead Medical Technologies, Covagen, Integral Spine Solutions, Maxillent, and Vaccibody.

BioPharmaceutical Medical Device
See All

Company Information

  • Industry
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
      • Minimally or Less Invasive
  • Therapeutic Areas
  • Dental & Oral Products
  • Musculoskeletal & Connective Tissue Disorders
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • Middle East
      • Israel
  • Parent & Subsidiaries
  • Maxillent Ltd.
  • Senior Management
  • Gideon Fostick, CEO
    Hadar Better, MD, CMO
    Tal Moyal, Dir., Sales & Mktg.
  • Contact Info
  • Maxillent Ltd.
    Phone: 9-9534500
    85 Medinat Hayehudim St.
    Bldg. G
    P.O. Box 4100 Herzliya, 46140